Post-Surgical Hypoparathyroidism
Endocrinology·MeSH: Hypoparathyroidism
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| yorvipath | Ascendis Pharma A/S (ASND) |
Phase 2(1)
| Drug | Company |
|---|---|
| encaleret | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Post-Surgical Hypoparathyroidism?
BioSniper tracks 2 drugs in development for Post-Surgical Hypoparathyroidism across 2 companies.
How many clinical trials target Post-Surgical Hypoparathyroidism?
There are 1 clinical trial targeting Post-Surgical Hypoparathyroidism tracked by BioSniper.
Deep-dive into Post-Surgical Hypoparathyroidism
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis